Rosiglitazone and retinoic acid inhibit proliferation and induce apoptosis in the HCT-15 human colorectal cancer cell line

Experimental and Therapeutic Medicine

Volumn 2, Issue 3, 2011, Pages 413-417

  Miao, Ruizheng ^a   Xu, Tao ^a   Liu, Liqing ^a   Wang, Meng ^a   Jiang, Yanming ^a   Li, Jianfeng ^a   Guo, Renle ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

All trans retinoic acid; Apoptosis; Proliferation; Rosiglitazone

Indexed keywords

CYCLOOXYGENASE 2; MATRILYSIN; RETINOIC ACID; ROSIGLITAZONE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PROTEIN EXPRESSION;

EID: 79953279097     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.227     Document Type: Article

References (22)

1. Issemann I and Green S: Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645-650, 1990.
2. Kersten S, Desvergne B and Wahli W: Roles of PRARS in health and disease. Nature 40: 421-424, 2000.
3. Mueller E, Smith M, Sarraf P, Kroll T, Aiyer A, Kaufman DS, Oh W, Demetri G, Figg WD, Zhou XR, Eng C, Spiegelman BM and Kantoff RW: Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Rroc Natl Acad Sci USA 97: 10990-10995, 2000.
4. Nagamine M, Okumura T, Tanno S, Sawamukai M, Motomura W, Takahashi N and Kohgo Y: RRARgamma ligand-induced apoptosis through a p53-dependent mechanism in human gastric cancer cells. Cancer Sci 94: 338-343, 2003.
5. Heaney AP, Fernando M and Melmed S: RRAR-gamma receptor ligands: novel therapy for pituitary adenomas. J Clin Invest 111: 1381-1388, 2003.
6. Yoshimura R, Matsuymma M, Segawa Y, Hase T, Mitsuhashi M, Tsuchida K, Wada S, Kawahito Y, Sano H and Nakatani T: Expression of peroxisome proliferator-activated receptors (RPARs) in human urinary bladder carcinoma and growth inhibition by its agonists. Int J Cancer 104: 597-602, 2003.
7. Guan YF, Zhang YH, Breyer RM, Davis L and Breyer MD: Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death. Neoplasia 1: 330-339, 1999.
8. Faueonnet S, Lascombe I, Chabannes E, Adessi GL, Desvergne B, Wahli W and Bittard H: Differential regulation of vascular endothelial growth factor expression by peroxisome proliferator-activated receptors in bladder cancer cells. J Biol Chem 277: 23534-23543, 2002.
9. Elstner E, Williamson EA, Zang C, Fritz J, Heber D, Fenner M, Possinger K and Koeffler HP: Novel therapeutic approach: ligands for PPARgamma and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells. Breast Cancer Res Treat 74: 155-165, 2002.
10. Zhou X, Zheng Q, Zhao X and Ma H: The inhibitory effect of elemene combined with tamoxifen on breast cancer cell line MCF-7. J Xi'an Jiaotong Univ Med Sci 28: 74-77, 2007.
11. Chawla A, Schwarz EJ, Dimaculangan DD and Lazar MA: Peroxisome proliferator activated receptor (RRAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology 135: 798-800, 1994.
12. Theocharis S, Giaginis C, Parasi A, Margeli A, Kakisis J, Agapitos E and Kouraklis G: Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patient survival. Dig Dis Sci 52: 2305-2311, 2007.
13. Elstner E, Muller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D and Koeffler HP: Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. Proc Natl Acad Sci USA 95: 8806-8811, 1998.
14. Shimada T, Kojima K, Yoshiura K, Hiraishi H and Terano A: Characteristics of the peroxisome proliferator-activated receptor γ (RRARγ) ligand induced apoptosis in colon cancer cells. Gut 50: 658-664, 2002.
15. Chang TH and Szabo E: Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor γ in non-small cell lung cancer. Cancer Res 60: 1129-1138, 2000.
16. Motomura W, Okumura T, Takahashi N, Obara T and Kohgo Y: Activation of peroxisome proliferator-activated receptorγ by troglitazone inhibits cell growth through the increases of R27kipl in human pancreatic carcinoma cells. Cancer Res 60: 5558-5564, 2000.
17. Liu JJ, Liu PQ, Lin DJ, Xiao RZ, Huang M, Li XD, He Y and Huang RW: Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonist-induced apoptosis in human monocyte leukemia cells in vitro. Ann Hematol 86: 173-183, 2007.
18. Yoshida K, Tanabe K, Fujii D, Oue N, Yasui W and Toge T: Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells. Anticancer Res 23: 267-273, 2003.
19. Murata H, Kawano S, Tsuji S, Tsuji M, Sawaoka H, Kimura Y, Shiozaki H and Hori M: Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 94: 451-460, 1999.
20. Yoshimoto M, Itoh F, Yamamoto H, Hinoda Y, Imai K and Yachi A: Expression of MMP-7 mRNA in human colorectal cancers. Int J Cancer 54: 614-619, 1993.
21. McDonnell S, Naver M, Coffey RJ Jr and Matrisian LM: Expression and localization of the matrix metalloproteinase pump21 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog 4: 527-536, 1991.
22. Baker AH, George SJ, Zaltsman AB, Murphy G and Newby AC: Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by over-expression of TIMR-3. Br J Cancer 79: 1347-1355, 1999.